Turtle Cameron

Chief Executive Officer at Spyre Therapeutics, Inc. · on record since Jun 30, 2023
Director at Oruka Therapeutics, Inc. · on record since Sep 6, 2024
Director at Damora Therapeutics, Inc. · on record since Mar 25, 2026
Director at Spyre Therapeutics, Inc. · on record since Apr 3, 2026
Chief Business Officer at Eidos Therapeutics, Inc. · on record since Nov 7, 2018
See Remarks at BridgeBio Pharma, Inc. · on record since Jun 27, 2019

Insider trading activity of Turtle Cameron

Transactions on record: 163; since Jun 6, 2019

Open-market buys: 0

Open-market sells: 81; $21.8M

Companies traded: 5; last filing Sep 3, 2026

Figures computed from official regulatory filings — .

Companies where Turtle Cameron has traded

Spyre Therapeutics, Inc.41 tx · $10M · Sep 3, 2026
Damora Therapeutics, Inc.1 tx · Mar 25, 2026
Oruka Therapeutics, Inc.1 tx · Jun 3, 2025
Eidos Therapeutics, Inc.59 tx · $9.2M · Jan 28, 2021
BridgeBio Pharma, Inc.61 tx · $4.4M · Dec 29, 2020

Track record of Turtle Cameron

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Turtle Cameron

Co-insiders of Turtle Cameron

Fairmount Funds Management LLCDamora Therapeutics, Inc. +2

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-3,700	88.06 USD	$325.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-8,400	87.15 USD	$732.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-2,500	86.36 USD	$215.9K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-400	89.07 USD	$35.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-7,157	95.10 USD	$680.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-5,635	95.93 USD	$540.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-16	97.46 USD	$1.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-800	93.97 USD	$75.2K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-1,392	96.82 USD	$134.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-4,234	88.12 USD	$373.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-10,176	87.44 USD	$889.8K	Unusual size	SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-590	88.91 USD	$52.5K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-3,294	71.38 USD	$235.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-8,149	70.50 USD	$574.5K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-3,557	69.40 USD	$246.9K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-300	74.96 USD	$22.5K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-5,300	69.54 USD	$368.6K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-1,000	71.76 USD	$71.8K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-3,100	73.14 USD	$226.7K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-1,700	74.23 USD	$126.2K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-3,600	70.77 USD	$254.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Apr 3, 2026	Sell	-2,656	49.92 USD	$132.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Apr 3, 2026	Sell	-12,344	49.20 USD	$607.3K		SEC
Damora Therapeutics, Inc.Listing unverified	Mar 25, 2026	AwardD (derivative)	37,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Mar 3, 2026	Sell	-9,100	42.49 USD	$386.7K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-3,700	88.06 USD	$325.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-8,400	87.15 USD	$732.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-2,500	86.36 USD	$215.9K		SEC
Spyre Therapeutics, Inc.Listing on record	Sep 3, 2026	Sell	-400	89.07 USD	$35.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-7,157	95.10 USD	$680.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-5,635	95.93 USD	$540.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-16	97.46 USD	$1.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-800	93.97 USD	$75.2K		SEC
Spyre Therapeutics, Inc.Listing on record	Aug 5, 2026	Sell	-1,392	96.82 USD	$134.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-4,234	88.12 USD	$373.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-10,176	87.44 USD	$889.8K	Unusual size	SEC
Spyre Therapeutics, Inc.Listing on record	Jul 2, 2026	Sell	-590	88.91 USD	$52.5K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-3,294	71.38 USD	$235.1K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-8,149	70.50 USD	$574.5K		SEC
Spyre Therapeutics, Inc.Listing on record	Jun 3, 2026	Sell	-3,557	69.40 USD	$246.9K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-300	74.96 USD	$22.5K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-5,300	69.54 USD	$368.6K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-1,000	71.76 USD	$71.8K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-3,100	73.14 USD	$226.7K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-1,700	74.23 USD	$126.2K		SEC
Spyre Therapeutics, Inc.Listing on record	May 1, 2026	Sell	-3,600	70.77 USD	$254.8K		SEC
Spyre Therapeutics, Inc.Listing on record	Apr 3, 2026	Sell	-2,656	49.92 USD	$132.6K		SEC
Spyre Therapeutics, Inc.Listing on record	Apr 3, 2026	Sell	-12,344	49.20 USD	$607.3K		SEC
Damora Therapeutics, Inc.Listing unverified	Mar 25, 2026	AwardD (derivative)	37,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Spyre Therapeutics, Inc.Listing on record	Mar 3, 2026	Sell	-9,100	42.49 USD	$386.7K		SEC